Molecules 2016, 21, 88
6 of 8
˝ ˝
-Bromo-2-naphthol (13) [23]: 9.05 mmol; 1.98 g (98%); Rt = 26.4 min; mp 80–82 C, lit [23] 82–83 C;
1
1
H-NMR
δ (500 MHz, CDCl ) 8.06 (1H, br d, J = 8.4 Hz, ArH), 7.81 (1H, br d, J = 8.1 Hz, ArH), 7.77 (1H,
3
d, J = 8.8 Hz, ArH), 7.60 (1H, ddd, J = 8.4, 6.9 and 1.2 Hz, ArH), 7.42 (1H, ddd, J = 8.1, 6.9 and 1.0 Hz,
ArH), 7.30 (1H, d, J = 8.8 Hz, ArH), 5.94 (1H, s, OH); 13C-NMR
δ
(126 MHz, CDCl ) 150.6 (C), 132.3 (C),
3
1
(81
29.7 (C), 129.4 (CH), 128.2 (CH), 127.9 (CH), 125.3 (CH), 124.2 (CH), 117.2 (CH), 106.2 (C); m/z (EI) 224
BrM , 98%), 222 ( BrM , 100), 115 (26), 114 (36).
+
79
+
1
2
-Bromo-4-tert-butylphenol (14) [26]: 10.1 mmol; 2.07 g (90%); Rt = 27.6 min; H-NMR
δ
(500 MHz,
CDCl ) 7.48 (1H, d, J = 2.3 Hz, ArH), 7.27 (1H, dd, J = 8.5 and 2.3 Hz, ArH), 6.99 (1H, d, J = 8.5 Hz, ArH),
3
13
5
1
7
.39 (1H, s, OH), 1.32 (9H, s, C(CH ) ); C-NMR δ (126 MHz, CDCl ) 149.9 (C), 145.1 (C), 128.8 (CH),
26.3 (CH), 115.6 (CH), 109.9 (C), 34.2 (C), 31.4 (3
4), 215 (100), 213 (86), 134 (87).
3 3 3
81
+
79
+
ˆ
CH ); m/z (EI) 230 ( BrM , 76%), 228 ( BrM ,
3
1
˝
3
9
-Bromo-[1,1 -biphenyl]-4-ol (
4
) [27]: 10.0 mmol; 2.22 g (89%); Rt = 24.2 min; mp 92–94 C, lit [27
˝
4–95 C; H-NMR δ (500 MHz, CDCl ) 7.70 (1H, d, J = 2.2 Hz), 7.56–7.48 (2H, m), 7.46 (1H, dd, J = 8.4
]
1
3
13
and 2.2, Hz), 7.44–7.39 (2H, m), 7.37–7.29 (1H, m), 7.09 (1H, d, J = 8.4 Hz), 5.52 (1H, s, OH); C-NMR
δ
(
1
8
126 MHz, CDCl ) 151.7 (C), 139.5 (C), 135.4 (C), 130.5 (CH), 128.9 (2
ˆ
CH), 128.0 (CH), 127.3 (CH),
3
81
+
79
+
26.8 (2
ˆ
CH), 116.3 (CH), 110.7 (C); m/z (EI) 250 ( BrM , 100%), 248 ( BrM , 100), 139 (38), 86 (58),
4 (99).
1
1
1
1
3
-Bromo-3 -fluoro-6 -methoxy-[1,1 -biphenyl]-4-ol (15): 3.49 mmol; 0.93 g (90%); Rt = 28.3 min; H-NMR
δ
(500 MHz, CDCl ) 7.67 (1H, d, J = 2.1 Hz, ArH), 7.41 (1H, dd, J = 8.4 and 2.1 Hz, ArH), 7.09 (1H, d,
3
J = 8.4 Hz, ArH), 7.03 (1H, ddd, J = 9.2, 3.1 and 0.7 Hz, ArH), 7.03–6.98 (1H, m, ArH), 6.91 (1H, ddd,
1
3
J = 8.7, 4.5 and 0.7 Hz, ArH), 5.57 (1H, s, OH), 3.81 (3H, s, OCH ); C-NMR
δ
(126 MHz, CDCl ) 157.1
3
3
1
4
4
(
(
1
8
d, J = 239 Hz, C), 152.5 (d, J = 2 Hz, C), 151.6 (C), 132.7 (CH), 131.3 (d, J = 2 Hz, C), 130.3
CH), 130.1 (d, J = 8 Hz, C), 117.1 (d, J = 24 Hz, CH), 115.6 (CH), 114.4 (d, J = 23 Hz, CH),
CF
CF
CF
2
3
2
CF
CF
CF
3
19
12.3 (d, J = 8 Hz, CH), 109.9 (C), 56.2 (CH ); F-NMR
δ
(471 MHz, CDCl3)
´
123.79 (ddd, J = 9.2,
CF
3
81
+
79
+
79
+
.3 and 4.5 Hz); m/z (EI) 298 ( BrM , 89%), 296 ( BrM , 90), 203 (20) 202 (100); HRMS (EI) BrM
79
found 295.9839, C H O BrF requires 295.9843.
13
10
2
Methyl (S)-2-tert-butoxycarbonylamino-3-(3-bromo-4-hydroxyphenyl)propanoate (ent-
6
): 5.00 mmol; 1.68 g
˝
α] = 59.0 (c 1, CHCl ); mp 117–119 C; H-NMR δ (500 MHz, CDCl , 323 K)
D 3 3
1
(
89%); Rt = 25.3 min; [
.24 (1H, d, J = 2.0 Hz, ArH), 6.97 (1H, dd, J = 8.3 and 2.0 Hz, ArH), 6.90 (1H, d, J = 8.3 Hz, ArH), 5.50
1H, br s, OH), 5.01 (1H, br s, NH), 4.51 (1H, br s, -CH), 3.71 (3H, s, OCH ), 3.04 (1H, dd, J = 14.0
and 5.8 Hz, CH H Ar), 2.97—2.88 (1H, m, CH H Ar), 1.43 (9H, s, C(CH ) ); C-NMR
7
(
α
3
13
δ
(126 MHz,
A
B
A
B
3 3
CDCl , 323 K) 172.2 (C), 155.2 (C), 151.8 (C), 133.0 (CH), 130.1 (CH), 129.8 (C), 116.3 (CH), 110.2 (C),
3
+
8
1
3
0.3 (C), 54.7 (CH), 52.3 (CH ), 37.5 (CH ), 28.4 (3
00%), 396 ([79BrM + Na] , 99), 374 (14) 342 (10), 340 (11); HRMS (ESI+, MeOH) [M + Na] found
96.0434, C H O N BrNa requires 396.0417.
ˆ
CH ); m/z (ESI+, MeOH) 398 ([81BrM + Na] ,
3
2
3
+
+
79
15
20
5
4
. Conclusions
In assessing the use of methanol as a carrier solvent for the mono ortho-bromination of phenols
by NBS under flow conditions, the “dark reaction” clearly indicated that UV-vis irradiation was
not a prerequisite for success. Thus batch reaction conditions were optimized to allow a range of
NBS-mediated mono ortho-bromination reactions to be carried out in ACS-grade methanol on gram
scale without UV-vis irradiation in reaction times of 25 min. The highly selective product distributions
achieved meant that the desired products of these reactions were readily purified in excellent yields
(
86%–98%), thus providing an extremely facile route to high value medicinal chemistry building blocks.
With an efficient route to the synthesis of the mono ortho-brominated derivative of Boc-D-Tyr-OMe in
hand, the synthesis of the intriguing anti-cancer natural product, bisebromoamide, may now be tackled.